Publication:
Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial

Simple item page
dc.contributor.authorÇAKIR, FATMA BETÜL
dc.contributor.authorYapar, Okan
dc.contributor.authorCanpolat, Cengiz
dc.contributor.authorAkalın, Figen
dc.contributor.authorBerrak, Su Gülsün
dc.contributor.institutionauthorÇAKIR, FATMA BETÜL
dc.date.accessioned2019-10-05T21:37:00Z
dc.date.available2019-10-05T21:37:00Z
dc.date.issued2012-10-01
dc.description.abstractCardiac side effects of granisetron have been studied mostly in adult patients that are using cardiotoxic chemotherapeutics. There is limited evidence in pediatric age group and no information in pediatric oncology patients with non-cardiotoxic chemotherapeutics.
dc.identifier
dc.identifier.citationÇAKIR F. B. , Yapar O., Canpolat C., Akalın F., Berrak S. G. , -Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial-, SUPPORTIVE CARE IN CANCER, cilt.20, ss.2451-2457, 2012
dc.identifier.pubmed22241602
dc.identifier.urihttps://hdl.handle.net/20.500.12645/7766
dc.language.isoen
dc.titleCardiac effects of granisetron in a prospective crossover randomized dose comparison trial
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameMOLECULAR DIVERSITY
local.avesis.idc10f9daa-595e-446e-b5d1-d4ea23fb1cec
local.avesis.response7642
local.indexed.atPubMed
relation.isAuthorOfPublication4b01ee0e-c087-44d4-9581-4d73032d078e
relation.isAuthorOfPublication.latestForDiscovery4b01ee0e-c087-44d4-9581-4d73032d078e

Files

Collections

Yayınlar - Eserler